BioRestorative Therapies Inc (BRTX)

BioRestorative Therapies Inc (BRTX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $3.1M; returns 1 day +8.0%, 1 week +5.2%, 1 year +2.9%.

BioRestorative Therapies Inc. (BRTX) is a clinical-stage regenerative medicine company specializing in developing therapeutic products primarily involving adult stem cells, alongside a commercial BioCosmeceutical platform.

Groups BRTX belongs to

• Recent Reverse Splits
• Regenerative Medicine
• Biotechnology
• Clinical Stage Biotech
• Autologous Cell Therapy
• Biologics
• Metabolic Disorders
• Clinical Stage
• Healthcare
• Pain Management

BRTX financial model: income statement, cash flow and balance sheet